Evidence map›Paper›PMID 35725769›Full record

ArticleNature cell biology2022

Hyaluronic acid-GPRC5C signalling promotes dormancy in haematopoietic stem cells.

Yu Wei Zhang, Julian Mess, Nadim Aizarani, Pankaj Mishra, Carys Johnson, Mari Carmen Romero-Mulero, Jasmin Rettkowski, Katharina Schönberger, Nadine Obier, Karin Jäcklein and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 5 countries.

Yu Wei ZhangMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Julian MessMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Nadim AizaraniMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Pankaj MishraPharmaceutical Bioinformatics, University of Freiburg, Freiburg, Germany.
Carys JohnsonDepartment of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Mari Carmen Romero-MuleroMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Jasmin RettkowskiMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Katharina SchönbergerMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Nadine ObierMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Karin JäckleinMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Nadine M WoessnerFaculty of Biology, University of Freiburg, Freiburg, Germany.
Maria-Eleni LaliotiMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Talia Velasco-HernandezJosep Carreras Leukemia Research Institute-Campus Clinic and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
Katarzyna SikoraMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Ralph WäschDepartment of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medical, University of Freiburg, Freiburg, Germany.
Bernhard LehnertzInstitute for Research in Immunology and Cancer, University of Montreal, Montreal, Canada.
Guy SauvageauInstitute for Research in Immunology and Cancer, University of Montreal, Montreal, Canada.
Thomas MankeMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Pablo MenendezSignalling Research Center BIOSS, Freiburg, Germany.
Sebastian Gottfried WalterDepartment of Orthopedic Surgery, University Hospital of Cologne, Cologne, Germany.
Susana MinguetFaculty of Biology, University of Freiburg, Freiburg, Germany.
Elisa LaurentiDepartment of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Stefan GüntherPharmaceutical Bioinformatics, University of Freiburg, Freiburg, Germany.
Dominic GrünMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Nina Cabezas-WallscheidMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. cabezas@ie-freiburg.mpg.de.ORCID http://orcid.org/0000-0003-0870-0530
University of Freiburg · DEMax Planck Institute of Immunobiology and Epigenetics · DEInstitute for Research in Immunology and Cancer · CAWellcome/MRC Cambridge Stem Cell Institute · GBInstitució Catalana de Recerca i Estudis Avançats · ESJosep Carreras Leukaemia Research Institute · ESUniversity Hospital Cologne · DE

Funding

Biotechnology and Biological Sciences Research Council BB/P002293/1Medical Research Council MC_PC_17230Wellcome TrustWellcome Trust 107630/Z/15/ZWellcome Trust 203151/Z/16/Z
6 · The paper itself

Abstract

Bone marrow haematopoietic stem cells (HSCs) are vital for lifelong maintenance of healthy haematopoiesis. In inbred mice housed in gnotobiotic facilities, the top of the haematopoietic hierarchy is occupied by dormant HSCs, which reversibly exit quiescence during stress. Whether HSC dormancy exists in humans remains debatable. Here, using single-cell RNA sequencing, we show a continuous landscape of highly purified human bone marrow HSCs displaying varying degrees of dormancy. We identify the orphan receptor GPRC5C, which enriches for dormant human HSCs. GPRC5C is also essential for HSC function, as demonstrated by genetic loss- and gain-of-function analyses. Through structural modelling and biochemical assays, we show that hyaluronic acid, a bone marrow extracellular matrix component, preserves dormancy through GPRC5C. We identify the hyaluronic acid-GPRC5C signalling axis controlling the state of dormancy in mouse and human HSCs.

Indexed as

Hematopoietic Stem CellsHyaluronic AcidAnimalsBone MarrowHematopoiesisHumansMiceSignal TransductionHyaluronic Acid

Identifiers

PMID35725769
PMCPMC9276531
OpenAlexW4283162937

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.